Synlogic Inc. (NASDAQ: SYBX) stock fell -2.36% on Wednesday to $0.62 against a previous-day closing price of $0.64. With 0.14 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.15 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.6816 whereas the lowest price it dropped to was $0.6200. The 52-week range on SYBX shows that it touched its highest point at $2.82 and its lowest point at $0.64 during that stretch. It currently has a 1-year price target of $7.60. Beta for the stock currently stands at 1.14.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SYBX was down-trending over the past week, with a drop of -12.93%, but this was down by -34.66% over a month. Three-month performance dropped to -40.79% while six-month performance fell -43.99%. The stock lost -74.10% in the past year, while it has lost -74.31% so far this year. A look at the trailing 12-month EPS for SYBX yields -0.90 with Next year EPS estimates of -0.93. For the next quarter, that number is -0.26. This implies an EPS growth rate of 33.70% for this year and 1.10% for next year.
Float and Shares Shorts:
At present, 72.11 million SYBX shares are outstanding with a float of 63.70 million shares on hand for trading. On Oct 13, 2022, short shares totaled 0.25 million, which was 0.35% higher than short shares on Sep 14, 2022. In addition to Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc as the firm’s Pres, CEO & Director, Mr. Antoine Awad serves as its Chief Operating Officer.
Through their ownership of 58.71% of SYBX’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 20.94% of SYBX, in contrast to 20.08% held by mutual funds. Shares owned by individuals account for 16.20%. As the largest shareholder in SYBX with 15.00% of the stake, Fidelity Management & Research Co holds 10,534,370 shares worth 10,534,370. A second-largest stockholder of SYBX, RA Capital Management LP, holds 4,618,415 shares, controlling over 6.58% of the firm’s shares. Alyeska Investment Group LP is the third largest shareholder in SYBX, holding 3,693,676 shares or 5.26% stake. With a 3.39% stake in SYBX, the Fidelity Growth Company Fund is the largest stakeholder. A total of 2,381,762 shares are owned by the mutual fund manager. The Vanguard Total Stock Market Index, which owns about 2.17% of SYBX stock, is the second-largest Mutual Fund holder. It holds 1,521,748 shares valued at 1.28 million. Fidelity VIP – Growth Portfolio holds 1.70% of the stake in SYBX, owning 1,192,500 shares worth 1.0 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SYBX since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With SYBX analysts setting a high price target of $8.00 and a low target of $7.00, the average target price over the next 12 months is $7.50. Based on these targets, SYBX could surge 1190.32% to reach the target high and rise by 1029.03% to reach the target low. Reaching the average price target will result in a growth of 1109.68% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. SYBX will report FY 2022 earnings on 03/16/2023. Analysts have provided yearly estimates in a range of -$0.92 being high and -$0.96 being low. For SYBX, this leads to a yearly average estimate of -$0.94. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Synlogic Inc. surprised analysts by -$0.02 when it reported -$0.25 EPS against a consensus estimate of -$0.23. The surprise factor in the prior quarter was $0.01. Based on analyst estimates, the high estimate for the next quarter is -$0.23 and the low estimate is -$0.27. The average estimate for the next quarter is thus -$0.26.
Summary of Insider Activity:
Insiders traded SYBX stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 4 while that of sell transactions has risen to 2 over the past year. The total number of shares bought during that period was 187,240 while 11,544 shares were sold.